Significant Shareholding Disclosure Report

Significant Shareholding Disclosure Report - KR / EN

First Half 2025 Financial Report

First Half 2025 Financial Report － KR / EN

Significant Shareholding Disclosure Report

Significant Shareholding Disclosure Report - KR / EN

[Amendment Report]Significant Shareholding Disclosure Report

[Amendment Report]Significant Shareholding Disclosure Report - KR / EN

Outcomes of Extraordinary General Meeting of Shareholders

Outcomes of Extraordinary General Meeting of Shareholders - KR / EN

Announces Grant of Stock Options

Announces Grant of Stock Options - KR / EN

Significant Shareholding Disclosure Report

Significant Shareholding Disclosure Report - KR / EN

Notice of Shareholders Meeting

Notice of Shareholders Meeting - KR / EN

[Amendment Report]Resolutions to Convene a General Meeting of Shareholders

[Amendment Report]Resolutions to Convene a General Meeting of Shareholders - KR / EN

Setting the Record Date (Share Register)

In accordance with Article 354 of the Korean Commercial Act and Article 14 of the Articles of Incorporation of Orum Therapeutics Inc., we hereby announce the record date as outlined below to determine shareholders eligible to exercise voting rights at the upcoming extraordinary general meeting.

1. Record Date (Shareholder Determination Date): July 10, 2025 (July 17, 2025)

2. Purpose: To determine the shareholders entitled to vote at the upcoming extraordinary general meeting.

Date: June 25, 2025

Orum Therapeutics Inc.

281-25 Munji-ro, Yuseong-gu, Daejeon, Korea

CEO Sung Joo Lee

Transfer Agent

Korea Securities Depository

CEO Soonho Lee

Setting the Record Date (Share Register) : KR / EN